V011-2554 Screening compound: 2-[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-[4-(trifluoromethyl)benzoyl]piperidine

V011-2554 Screening compound: 2-[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-[4-(trifluoromethyl)benzoyl]piperidine
V011-2554 Screening compound: 2-[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-[4-(trifluoromethyl)benzoyl]piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-2554
2-[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-[4-(trifluoromethyl)benzoyl]piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-2554

Molecular Formula

C22H20F3N3O3 (C22 H20 F3 N3 O3)

Compound Name

2-[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-[4-(trifluoromethyl)benzoyl]piperidine

IUPAC name

2-[3-(3-methoxyphenyl)-124-oxadiazol-5-yl]-1-[4-(trifluoromethyl)benzoyl]piperidine

SMILES

COc1cccc(-c2noc(C(CCCC3)N3C(c3ccc(C(F)(F)F)cc3)=O)n2)c1

InChI

InChI=1S/C22H20F3N3O3/c1-30-17-6-4-5-15(13-17)19-26-20(31-27-19)18-7-2-3-12-28(18)21(29)14-8-10-16(11-9-14)22(23,24)25/h4-6,8-11,13,18H,2-3,7,12H2,1H3/t18-/m0/s1

InChI Key

MNAILZZUUMNAIH-SFHVURJKSA-N

MDL Number (MFCD)

MFCD19727824

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

431.41

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.485

Distribution Coefficient, logD

5.485

Water Solubility, LogSw

-5.47

Polar Surface Area

55.530

Acid Dissociation Constant (pKa)

26.58

Base Dissociation Constant (pKb)

-4.57

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

31.80

V011-2554 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with V011-2554 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-2554?
Check Price and Availability of V011-2554, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-2554 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-2554
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-2554
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-2554 available by request